CA2125192A1 - Procede de generation d'une diversite structurale et fonctionnelle dans une sequence peptidique - Google Patents

Procede de generation d'une diversite structurale et fonctionnelle dans une sequence peptidique

Info

Publication number
CA2125192A1
CA2125192A1 CA002125192A CA2125192A CA2125192A1 CA 2125192 A1 CA2125192 A1 CA 2125192A1 CA 002125192 A CA002125192 A CA 002125192A CA 2125192 A CA2125192 A CA 2125192A CA 2125192 A1 CA2125192 A1 CA 2125192A1
Authority
CA
Canada
Prior art keywords
rag
sequences
sequence
vectors
genes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002125192A
Other languages
English (en)
French (fr)
Inventor
Sacha Kallenbach
Noelle Doyen
Francois Rougeon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2125192A1 publication Critical patent/CA2125192A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C12N15/1024—In vivo mutagenesis using high mutation rate "mutator" host strains by inserting genetic material, e.g. encoding an error prone polymerase, disrupting a gene for mismatch repair
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C12N9/1264—DNA nucleotidylexotransferase (2.7.7.31), i.e. terminal nucleotidyl transferase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002125192A 1991-12-11 1992-12-11 Procede de generation d'une diversite structurale et fonctionnelle dans une sequence peptidique Abandoned CA2125192A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9115389 1991-12-11
FR9115389A FR2685004A1 (fr) 1991-12-11 1991-12-11 Procede de generation d'une diversite structurale et fonctionnelle dans une sequence peptidique.

Publications (1)

Publication Number Publication Date
CA2125192A1 true CA2125192A1 (fr) 1993-06-24

Family

ID=9419935

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002125192A Abandoned CA2125192A1 (fr) 1991-12-11 1992-12-11 Procede de generation d'une diversite structurale et fonctionnelle dans une sequence peptidique

Country Status (11)

Country Link
US (1) US5756323A (https=)
EP (1) EP0618965B1 (https=)
JP (1) JPH07504086A (https=)
AT (1) ATE322543T1 (https=)
CA (1) CA2125192A1 (https=)
DE (1) DE69233612T2 (https=)
DK (1) DK0618965T3 (https=)
ES (1) ES2260753T3 (https=)
FR (1) FR2685004A1 (https=)
PT (1) PT618965E (https=)
WO (1) WO1993012228A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
DK1036198T3 (da) 1997-12-08 2013-01-02 California Inst Of Techn Fremgangsmåde til fremstilling af polynukleotid- og polypeptidsekvenser
US7122339B2 (en) 1998-10-09 2006-10-17 Medical Research Council Method for generating diversity
DK1117774T3 (da) * 1998-10-09 2010-05-03 Medical Res Council Fremgangsmåde til diversitetsgenerering
EP1010763A1 (en) * 1998-12-11 2000-06-21 Institut Pasteur Enhanced expression of heterologous proteins in recombinant bacteria through reduced growth temperature and co-expression of rare tRNA's
US6977245B2 (en) 1999-04-12 2005-12-20 The United States Of America As Represented By The Department Of Health And Human Services Oligodeoxynucleotide and its use to induce an immune response
WO2005007823A2 (en) * 2003-07-11 2005-01-27 New York University Compositions, kits, and methods for stimulation of homologous recombination
BRPI0807952A2 (pt) 2007-02-20 2014-06-10 Anaptysbio Inc Sistemas de hipermutação somática
WO2009129247A2 (en) * 2008-04-14 2009-10-22 Innovative Targeting Solutions Inc. Sequence diversity generation in immunoglobulins
EP2412806B1 (en) 2010-07-28 2014-01-08 Institut Pasteur Use of terminal deoxynucleotidyl transferase for mutagenic DNA repair to generate variability, at a determined position in DNA
EP2825653A4 (en) 2012-03-14 2016-01-20 Innovative Targeting Solutions Inc PRODUCTION OF TARGETED SEQUENCE DIVERSITY IN FUSION PROTEINS
WO2013134880A1 (en) 2012-03-14 2013-09-19 Innovative Targeting Solutions Inc. Generating targeted sequence diversity in proteins

Also Published As

Publication number Publication date
WO1993012228A1 (fr) 1993-06-24
DE69233612T2 (de) 2007-07-05
PT618965E (pt) 2006-08-31
JPH07504086A (ja) 1995-05-11
ES2260753T3 (es) 2006-11-01
EP0618965B1 (fr) 2006-04-05
DE69233612D1 (de) 2006-05-18
EP0618965A1 (fr) 1994-10-12
FR2685004B1 (https=) 1995-01-06
ATE322543T1 (de) 2006-04-15
FR2685004A1 (fr) 1993-06-18
DK0618965T3 (da) 2006-08-14
US5756323A (en) 1998-05-26

Similar Documents

Publication Publication Date Title
US20250340907A1 (en) Methods and compositions for modulating a genome
US20230242899A1 (en) Methods and compositions for modulating a genome
DE112020001339T5 (de) Verfahren und zusammensetzung zum editing von nukleotidsequenzen
DE112021002672T5 (de) Vefahren und zusammensetzungen zum gleichzeitigen editieren beider stränge einer doppelsträngigen nukleotid-zielsequenz
Feeney et al. A defective Vkappa A2 allele in Navajos which may play a role in increased susceptibility to haemophilus influenzae type b disease.
DE69615406T3 (de) Verfahren zur herstellung von polynukleotiden mit gewünschten eigenschaften durch iterative selektion und rekombination
CN111757937A (zh) 腺苷碱基编辑器的用途
KR20230076820A (ko) 진핵생물 유전체 공학을 위한 합성 미니어처 crispr-cas(casmini) 시스템
US20240287453A1 (en) Persistent allogeneic modified immune cells and methods of use thereof
JPH08503856A (ja) 相同組み換えによる内因性遺伝子の発現の活性化及び増幅
CN109475109A (zh) 用于使用多个引导rna来破坏免疫耐受性的方法
Zhang et al. The role of short homology repeats and TdT in generation of the invariant γδ antigen receptor repertoire in the fetal thymus
JPWO2020191243A5 (https=)
JPH10508493A (ja) 組換えイースト人工染色体を作製する方法
CA2125192A1 (fr) Procede de generation d'une diversite structurale et fonctionnelle dans une sequence peptidique
US20230348939A1 (en) Methods and compositions for modulating a genome
US20240200104A1 (en) Ltr transposon compositions and methods
JP7641233B2 (ja) 改善された遺伝子編集のための組成物及び方法
CN121586577A (zh) 基因组编辑组合物及使用方法
Silaeva et al. Gene editing CRISPR/Cas9 system for producing cows with hypoallergenic milk on the background of a beta-lactoglobulin gene knockout
CA2341350A1 (en) Transgenic animals produced by homologous sequence targeting
CN118234865A (zh) 持久性同种异体修饰免疫细胞及其使用方法
EP1364007A1 (en) Circular extra-chromosomal dna elements
EP2641967A1 (en) Method for producing b-cell capable of producing human-type antibody
Guo Generation of endoplasmic reticulum protein 28 (ERp28) knock out mice, and structural and functional analysis of its Drosophila Homologue, Wind

Legal Events

Date Code Title Description
FZDE Discontinued